胸外科手术后心肌损伤的研究进展  

Advances in the study of myocardial injury after thoracic surgery

作　　者：林姝池 刘金东 LIN Shuchi;LIU Jindong(Department of Anesthesiology,the Affiliated Hospital of Xuzhou Medical University,Xuzhou 221002,China)

机构地区：[1]徐州医科大学附属医院麻醉科,221002

出　　处：《临床麻醉学杂志》2023年第3期313-317,共5页Journal of Clinical Anesthesiology

摘　　要：近年来,随着胸外科手术患者逐年增加,胸外科手术后心肌损伤的发生率也不容小觑。因为患者很少出现与心肌缺血相关的症状,所以识别术后心肌损伤相当棘手。据估计,胸外科手术期间或术后30 d内约有27%的患者患有心肌损伤。患者术后发生心肌损伤与住院时间延长、医疗费用增加和远期死亡率的增加密切相关。目前尚缺乏针对术后心肌损伤有效的治疗手段。因此,早期识别、尽早诊断、及时干预对术后心肌损伤至关重要。本文结合近几年国内外相关文献,主要对胸外科手术后心肌损伤的流行病学、诊断标准、危险因素、相关生物标记物及预防和治疗进行综述,旨在为提高临床管理水平提供指导依据。In recent years,with the increasing number of patients undergoing thoracic surgery,the incidence of myocardial injury after thoracic surgery should not be underestimated.Patients rarely have symptoms related to myocardial ischemia,so it is difficult to identify postoperative myocardial injury.It is estimated that about 27%patients suffer from myocardial injury during or within 30 days after thoracic surgery.Postoperative myocardial injury is associated with long hospitalization time,increased medical expenses,and long-term renal insufficiency.At present,there is no effective treatment for postoperative myocardial injury.Therefore,early identification,early diagnosis,and timely intervention are of vital importance for postoperative myocardial injury.In this paper,the epidemiology,diagnostic criteria,risk factors,and related biomarkers of myocardial injury,prevention,and treatment after thoracic surgery are reviewed with the aim of providing guidance for improving clinical management.

关 键 词：胸外科手术 心肌损伤 危险因素 生物标志物 

分 类 号：R655[医药卫生—外科学]